Premium
Treatment of chronic hepatitis B
Author(s) -
Lok A. S. F.
Publication year - 1994
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/j.1365-2893.1994.tb00110.x
Subject(s) - medicine , chronic hepatitis , interferon , clinical trial , hepatitis b virus , hepatitis b , immunology , intensive care medicine , virology , virus
SUMMARY. Chronic infection with the hepatitis B virus (HBV) is a major cause of worldwide morbidity and mortality. A large number of therapeutic approaches has been tried, including interferon (IFN), nucleoside analogues and immunomodulators. To date controlled clinical trials have shown that only IFN is of long‐term value but many patients fail to respond to treatment. New approaches to treating patients with IFN‐resistant hepatitis B are currently undergoing clinical and experimental evaluation, and it seems likely that new therapeutic agents will be available in the near future.